Study of a New Topical Natural Health Product for the Treatment of Herpes

See also
Status	Clinical Trial	Phase
Completed	`NCT02483182` - Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores	Phase 2
Completed	`NCT00297011` - Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis	Phase 2
Completed	`NCT03310294` - Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis	N/A
Terminated	`NCT04539483` - Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection	Phase 2
Completed	`NCT02265913` - Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis	Phase 3
Completed	`NCT01971385` - Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis	Phase 1
Active, not recruiting	`NCT01695187` - NB-001 Treatment of Recurrent Herpes Labialis	Phase 3
Completed	`NCT00375570` - Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents	Phase 3
Completed	`NCT02871492` - Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes	Phase 2
Completed	`NCT01484067` - Study of a Cold Sore Patch for the Treatment of Herpes Labialis	N/A
Completed	`NCT00769314` - Phase 3 Clinical Study for the Treatment of Cold Sore	Phase 3
Completed	`NCT00878072` - Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis	Phase 2/Phase 3
Completed	`NCT01574612` - Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old	Phase 3
Completed	`NCT03661541` - Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)	Phase 1
Recruiting	`NCT01306084` - Viral Infections in Healthy and Immunocompromised Hosts
Terminated	`NCT03521479` - A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis	Phase 2
Terminated	`NCT00913692` - A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis	Phase 2
Completed	`NCT02207881` - A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis	Phase 2
Completed	`NCT01653509` - An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode	Phase 1
Completed	`NCT00361881` - Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis	Phase 3

NCT number	NCT02582086
Study type	Interventional
Source	Laboratoire Boreaderme Inc.
Contact	Elisabeth EF Fiquet, M. Sc
Phone	5143430001
Email	efiquet@evalulab.com
Status	Recruiting
Phase	N/A
Start date	January 2016
Completion date	September 2017

Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms